QuintilesIMS Continuous Glucose Monitoring offers a more complete view of the daily measures of glucose levels and variability than the traditional measures of glucose control by self-monitored blood glucose (SMBG) and HbA1c, promoting enhanced patient safety and clinical outcomes. Our innovative platform – combined with leading operational and therapeutic expertise – captures, cleans and analyzes glucose data, enabling meaningful compound differentiation. To learn more, download our infographic.